Skip to Content
Rekenthaler Report

Interval Funds: A Dissenting Opinion

A reader disputes Wednesday’s column.


Taking Exception 
Sometimes, my articles can’t be reasonably rebutted. That  PIMCO Total Return (PTTRX) survived Bill Gross’ departure, or that target-date funds were inspired by academic research, is not up for debate. Other times, though, there is room for disagreement.

To view this article, become a Morningstar Basic member.

Register for Free

John Rekenthaler has a position in the following securities mentioned above: PTTRX. Find out about Morningstar’s editorial policies.